Tafenoquine Market

Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.

Tafenoquine Market contains market size and forecasts of Tafenoquine in global, including the following market information:

• Global Tafenoquine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Tafenoquine Market Sales, 2017-2022, 2023-2028, (Tons)
• Global top five Tafenoquine companies in 2021 (%)

The global Tafenoquine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tafenoquine include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tafenoquine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tafenoquine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Tafenoquine Market Segment Percentages, by Type, 2021 (%)

• Powder
• Pills

Global Tafenoquine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Tafenoquine Market Segment Percentages, by Application, 2021 (%)

• Radical Cure of P.vivax
• P. falciparum Treatment
• Prevention of Malaria Relapse

Global Tafenoquine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Tafenoquine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Tafenoquine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Tafenoquine revenues share in global market, 2021 (%)
• Key companies Tafenoquine sales in global market, 2017-2022 (Estimated), (Tons)
• Key companies Tafenoquine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline Pharmaceuticals (GSK)
• J & K Scientific LTD
• BOC Sciences
• WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
• Pharmacodia (Beijing) Co.,Ltd
• Amadis Chemical Company Limited
• Merck